The Missing Link Between Evidence and Patient Care

Why discovering effective therapies is only the beginning of improving patient outcomes.

A patient with heart failure arrives for a cardiology appointment. That same patient also lives with diabetes, chronic kidney disease, hypertension, and obesity. Over the next several months they will see a primary care physician, a cardiologist, a nephrologist, an endocrinologist, and a pharmacist. Every clinician brings specialized expertise and a sincere commitment to helping the patient. Without coordination, however, even the strongest scientific evidence can become fragmented across multiple visits, competing priorities, and separate healthcare systems.

That is the problem implementation science exists to solve.

When people ask what I do, I often answer that I work in implementation science. The response is often followed by a pause because the discipline remains unfamiliar outside the research community. Even within healthcare, many professionals have never encountered the term.

My path to implementation science did not begin in a research office. It began at the bedside. I spent fifteen years in cardiovascular clinical care and healthcare administration before transitioning into implementation science nearly a decade ago. Experiencing healthcare from the bedside, through healthcare administration, and now through the lens of implementation science has shaped the way I think about improving care. Each role revealed a different part of the healthcare system, yet all of them led me to the same conclusion: discovering better treatments is only part of the work. The greater challenge is ensuring every patient can benefit from those discoveries.

Implementation science examines how evidence-based care becomes routine clinical practice. Clinical research determines whether an intervention is safe and effective. Implementation science asks a different question: once that evidence exists, how do we ensure every patient who stands to benefit actually receives it?

My work focuses on cardiovascular, renal, and metabolic disease, where patients frequently live with multiple chronic conditions that influence one another. Heart failure, chronic kidney disease, diabetes, hypertension, obesity, and cardiovascular disease seldom exist in isolation. As a result, patients often receive care from primary care physicians, cardiologists, nephrologists, endocrinologists, pharmacists, advanced practice providers, nurses, dietitians, and many other healthcare professionals.

Every member of the care team contributes expertise shaped by their specialty. The challenge is ensuring that those perspectives remain aligned around the same evidence-based goals. A therapy recommended by one clinician may influence decisions made by another, making communication and coordination essential. Guideline-directed medical therapy achieves its greatest benefit when every provider caring for the patient has a shared understanding of the evidence and a common commitment to implementing it consistently.

Evidence supporting guideline-directed medical therapy continues to expand. Clinical trials have demonstrated meaningful reductions in mortality, hospitalization, disease progression, and cardiovascular events across numerous therapeutic classes. Pharmaceutical companies invest extraordinary resources to discover, develop, and evaluate these therapies before they ever reach regulatory approval. Bringing a single therapy to market requires years of scientific investigation and frequently billions of dollars in investment.

Regulatory approval, however, represents only one milestone in a much longer journey.

A therapy cannot improve outcomes unless it reaches the patients for whom it was intended. Regulatory approval creates that opportunity, but it does not guarantee implementation. Healthcare systems remain extraordinarily complex, and translating evidence into routine practice requires far more than publishing a clinical trial or updating a guideline. The gap between what medicine knows and what patients experience is often referred to as the evidence-to-practice gap. Implementation science exists to close that gap.

Our work identifies why proven therapies remain underutilized, examines the barriers that prevent evidence from becoming routine practice, and develops practical strategies that help healthcare systems deliver evidence-based care more consistently. It also examines clinical workflows, organizational culture, interdisciplinary communication, health policy, implementation strategies, patient engagement, and system-level barriers that influence whether evidence becomes routine practice. Healthcare functions as an interconnected system in which every decision influences the next point of care, making collaboration essential to sustainable improvement.

Implementation research receives only a fraction of the investment devoted to therapeutic discovery. That imbalance is understandable because scientific innovation deserves substantial financial support. New therapies cannot improve lives until they are discovered, rigorously tested, and approved. Unfortunately, bringing a proven therapy to market does not necessarily mean that therapy will reach every eligible patient. Closing that gap requires a different kind of scientific inquiry, one that focuses on understanding how evidence becomes everyday care.

One aspect of implementation science deserves greater attention: sustainability.

Much of my work involves partnering with health systems to design implementation strategies that fit their unique clinical environments. Every health system differs in its patient population, available resources, organizational culture, clinical workflows, and operational priorities. Effective implementation cannot rely on a universal solution because healthcare is delivered within complex systems that function differently from one organization to another.

Successful implementation depends upon adapting evidence-based strategies to local contexts while preserving the essential elements that make those strategies effective. What succeeds in one health system may require thoughtful modification in another, yet the underlying evidence must remain intact.

Our goal extends beyond improving care during the life of a study.

Our responsibility is to build processes that become part of routine clinical care and continue improving outcomes long after the research has concluded. Sustainable implementation represents one of the most meaningful measures of success because lasting change continues benefiting patients after the study team has stepped away.

Does that always happen? It does not.

Some implementation strategies become embedded within clinical practice. Others encounter barriers that cannot be fully overcome despite years of planning, collaboration, and refinement. Healthcare continues to evolve, leadership changes, priorities shift, and competing demands influence every organization.

Those realities can be discouraging. We continue pressing forward because this work has never been about us.

Publishing manuscripts, securing grants, completing studies, and presenting scientific findings all matter because they create opportunities to improve care. Those achievements are important, but they have never been the destination.

The destination has always been ensuring every patient receives the care they deserve.

Throughout my career, I have carried patient stories with me. I think about individuals living with multiple chronic conditions while navigating appointments across several specialties. I think about families trying to understand complex medication regimens, patients struggling to afford life-saving therapies, and people whose opportunities for better outcomes depend upon whether healthcare systems successfully translate evidence into practice.

Meaningful progress is often achieved one workflow, one partnership, one strategy, and one health system at a time. During difficult seasons, it becomes easy to focus on timelines, milestones, funding cycles, regulatory requirements, and the countless operational details that accompany research. Patient stories remind me why those details matter. Behind every implementation strategy is a person waiting for healthcare to work as well in practice as it does on paper. This work has never been about individual accomplishments. It has always been about creating healthcare systems capable of delivering the best available care to every person who entrusts us with their care.

Writing this essay has served another purpose.

More often than I care to admit, I need this reminder myself.

Putting these thoughts into words has reminded me why I chose this field and why I continue returning to the same mission.

More importantly, it has reminded me of the privilege of working alongside extraordinary colleagues, investigators, implementation scientists, clinicians, research coordinators, data teams, sponsors, and participating healthcare systems that dedicate themselves to improving patient care every single day. None of this work is accomplished alone.

Scientific discovery gives us evidence.

Implementation gives that evidence the opportunity to change lives.

Every patient deserves more than scientific discovery; every patient deserves the opportunity to benefit from it.

© 2026 Monica A. Leyva. All rights reserved.

If this essay resonated with you, I invite you to consider becoming a paid subscriber. Your support allows me to continue exploring healthcare, research, and the stories that remind us why this work matters. Free subscribers will always have a place here.

Leave a comment